In line with our observations, lower abundance of circulating antennary fucosylated AGP was a good predictor of response and increased survival after ICI treatment with nivolumab in a smaller cohort of 39 patients with lung cancer [25]. The gene discussed is ATP5MK; the disease is lung carcinoma.